Bridgeway Capital Management, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.55 - $2.15 $155,000 - $215,000	-100,000 Reduced 49.4%	102,440 $187,000
Q1 2021 May 17, 2021	BUY	$1.99 - $2.9 $184,075 - $268,250	92,500 Added 84.14%	202,440 $409,000
Q4 2020 Feb 16, 2021	SELL	$1.88 - $2.84 $42,488 - $64,184	-22,600 Reduced 17.05%	109,940 $236,000
Q3 2020 Nov 16, 2020	BUY	$2.69 - $4.95 $188,300 - $346,500	70,000 Added 111.93%	132,540 $358,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $43,778 - $260,166	62,540 New	62,540 $246,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.